FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fernando Gomollón

Research Profile

Living Beings

Helicobacter pylori

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Spain

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Javier P Gisbert; Fernando Gomollón; Angel Lanas; Carlos Martín de Argila; Adrián G McNicholl; Fermín Mearin; Javier Molina Infante; Miguel Montoro; José María Pajares; Angeles Pérez-Aisa; Emilio Pérez-Trallero; F Bermejo; Daniel Boixeda; Felipe Bory; Luis Bujanda; Xavier Calvet; Manuel Castro-Fernández; Enrique Dominguez-Muñoz; Juan Ignasi Elizalde; Montserrat Forné; Emili Gené; Jordi Sánchez-Delgado
[III Spanish Consensus Conference on Helicobacter pylori infection].
Tiago Nunes; Miquel Sans; Carles Agustí; Maite Arroyo; Manuel Barreiro-de Acosta; Guillermo Bastida; Maria Josefina Etchevers; Carolina Figueroa; Sonia Gallego; Sara García; Esther García-Planella; Valle García-Sánchez; Elena Gento; Daniel Ginard; Fernando Gomollón; Benito Gonzalez; Carme Loras; Ignacio Marín-Jiménez; Eva Martí; Luis Menchén; Olga Merino; David Monfort
High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN Study.
José Luis Cabriada; Eugeni Domènech; María Esteve; Javier P Gisbert; Fernando Gomollón; Julia Panés; Isabel Vera; Manuel Barreiro-de Acosta
[Recommendations of the Spanish Working Group on Crohn's disease and ulcerative colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fernando Gomollón (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Javier P Gisbert; Fernando Gomollón; Angel Lanas; Carlos Martín de Argila; Adrián G McNicholl; Fermín Mearin; Javier Molina Infante; Miguel Montoro; José María Pajares; Angeles Pérez-Aisa; Emilio Pérez-Trallero; F Bermejo; Daniel Boixeda; Felipe Bory; Luis Bujanda; Xavier Calvet; Manuel Castro-Fernández; Enrique Dominguez-Muñoz; Juan Ignasi Elizalde; Montserrat Forné; Emili Gené; Jordi Sánchez-Delgado
[III Spanish Consensus Conference on Helicobacter pylori infection].
Gastroenterología y hepatología 2013;36(5):340-74.
2013: Tiago Nunes; Miquel Sans; Carles Agustí; Maite Arroyo; Manuel Barreiro-de Acosta; Guillermo Bastida; Maria Josefina Etchevers; Carolina Figueroa; Sonia Gallego; Sara García; Esther García-Planella; Valle García-Sánchez; Elena Gento; Daniel Ginard; Fernando Gomollón; Benito Gonzalez; Carme Loras; Ignacio Marín-Jiménez; Eva Martí; Luis Menchén; Olga Merino; David Monfort
High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN Study.
Journal of Crohn's & colitis 2013;7(3):202-7.
2013: José Luis Cabriada; Eugeni Domènech; María Esteve; Javier P Gisbert; Fernando Gomollón; Julia Panés; Isabel Vera; Manuel Barreiro-de Acosta
[Recommendations of the Spanish Working Group on Crohn's disease and ulcerative colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].
Gastroenterología y hepatología 2013;36(3):127-46.
2013: M J Casanova; M Chaparro; Eugeni Domènech; C Dueñas; Maria Esteve; S García-López; Esther García-Planella; V García-Sánchez; E Garrido; Daniel Ginard; María Gómez-García; Fernando Gomollón; E Iglesias; M López; Míriam Mañosa; José Maté; J L Pérez-Calle; Mireia G Piqueras; Angel Ponferrada; Luis Rodrigo; C Saro; carlos taxonera; Manuel Barreiro-de Acosta; B Beltrán; F Bermejo; B Botella; Xavier Calvet; M Calvo; Javier P Gisbert
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
The American journal of gastroenterology 2013;108(3):433-40.
2013: Fernando Gomollón; Javier P Gisbert
Intravenous iron in inflammatory bowel diseases.
Current opinion in gastroenterology 2013;29(2):201-7.
2013: Fernando Gomollón; Santiago García-López; Javier P Gisbert; Beatriz Sicilia; Joaquín Hinojosa
Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.
Gastroenterología y hepatología 2013;36(2):104-14.
2013: Alberto Mir Subías; Leticia Ollero Domenche; Berta Sebastián Torres; Andrés García Gámez; Santiago García-López; Fernando Gomollón
[Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease].
Gastroenterología y hepatología 2013;36(2):81-5.
2013: Gert Van Assche; Laurent Beaugerie; Bernd Bokemeyer; Silvio Danese; Axel Dignass; Paolo Gionchetti; Fernando Gomollón; Winfried Häuser; Klaus Herrlinger; Gabriele Moser; Bas Oldenburg; Julian Panes; Francisco Portela; Gerhard Rogler; Jürgen Stein; Herbert Tilg; Simon Travis; James O Lindsay
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
Journal of Crohn's & colitis 2013;7(1):1-33.
2013: Tiago Nunes; Miquel Sans; Carles Agustí; Maite Arroyo; Manuel Barreiro-de Acosta; Guillermo Bastida; Maria Josefina Etchevers; Carolina Figueroa; Sonia Gallego; Sara García; Esther García-Planella; Valle García-Sánchez; Elena Gento; Daniel Ginard; Fernando Gomollón; Benito Gonzalez; Carme Loras; Ignacio Marín-Jiménez; Luis Menchén; Olga Merino; David Monfort
Does smoking influence Crohn's disease in the biologic era? The TABACROHN study.
Inflammatory bowel diseases 2013;19(1):23-9.
2012: Fernando Gomollón
[The future of inflammatory bowel disease from the perspective of Digestive Disease Week 2012].
Gastroenterología y hepatología 2012;35 Suppl 1():43-50.
2012: Edouard Louis; Daniel Baumgart; Subrata Ghosh; Fernando Gomollón; Stephen Hanauer; Ailsa Hart; Peter Irving
What changes in inflammatory bowel disease management can be implemented today?
Journal of Crohn's & colitis 2012;6 Suppl 2():S260-7.
2012: M Chaparro; Esther García-Planella; M Barreiro-de Acosta; Guillermo Bastida; P Burgueño; Xavier Calvet; L Castro; M Gómez; Fernando Gomollón; V Hernández; J Hinojosa; E Iglesias; C Jiménez; Míriam Mañosa; J L Mendoza; F Muñoz; O Pérez Nyssen; Julián Panés; S Gómez Senent; Javier P Gisbert
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Alimentary pharmacology & therapeutics 2012;35(2):275-83.
2011: Fernando Gomollón
[Constant evolution of key concepts in inflammatory bowel disease. Some perspectives from Digestive Disease Week 2011].
Gastroenterología y hepatología 2011;34 Suppl 2():43-51.
2011: Fernando Gomollón; Javier P Gisbert
IBD: Intravenous iron in IBD--what's the best preparation?
Nature reviews. Gastroenterology & hepatology 2011;8(9):477-8.
2011: Javier P Gisbert; María Chaparro; Fernando Gomollón
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
World journal of gastroenterology : WJG 2011;17(30):3467-78.
2011: María Chaparro; Julián Panes; Valle García; Miriam Mañosa; María Esteve; Olga Merino; Montserrat Andreu; Ana Gutierrez; Fernando Gomollón; José Luis Cabriada; Miguel Angel Montoro; Juan Luis Mendoza; Pilar Nos; Javier P Gisbert
Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
Journal of clinical gastroenterology 2011;45(2):113-8.
2010: Javier P Gisbert; Fernando Gomollón; J Hinojosa; A López San Román
Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.
Journal of Crohn's & colitis 2010;4(5):567-74.
2010: Fermín Mearin; Agustín Balboa; Antoni Castells; J Enrique Domínguez; Maria Esteve; Jose A García-Erce; Javier Pérez Gisbert; Fernando Gomollón; Julián Panés; Javier P Gisbert; Julio Ponce
[Iron deficiency anemia and use of intravenous iron in digestive disease].
Gastroenterología y hepatología 2010;33(8):605-13.
2010: Fernando Gomollón; Javier P Gisbert; José Antonio Garcia-Erce
Intravenous iron in digestive diseases: a clinical (re)view.
Therapeutic advances in chronic disease 2010;1(2):67-75.
2010: Fernando Gomollón; Javier P Gisbert
[Must immunomodulators be added to biological treatment in inflammatory bowel disease?].
Gastroenterología y hepatología 2010;33(1):43-53.
2009: José Antonio Garcia-Erce; Fernando Gomollón; Manuel Muñoz
Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases.
World journal of gastroenterology : WJG 2009;15(37):4686-94.
2009: Fernando Gomollón; Javier P Gisbert
Anemia and inflammatory bowel diseases.
World journal of gastroenterology : WJG 2009;15(37):4659-65.
2009: Fernando Gomollón; Javier P Gisbert
Anemia and digestive diseases: an update for the clinician.
World journal of gastroenterology : WJG 2009;15(37):4615-6.
2009: Javier P Gisbert; P M Linares; A G McNicholl; José Maté; Fernando Gomollón
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Alimentary pharmacology & therapeutics 2009;30(2):126-37.
2009: Vanesa Bernal; Fernando Gomollón
Diagnosis of Clostridium difficile-associated diarrhea.
Journal of Crohn's & colitis 2009;3(2):137.
2009: Beatriz Sicilia; Raquel Vicente; Fernando Gomollón
[Epidemiology of inflammatory bowel disease: controversies in classical epidemiology].
Acta gastroenterologica Latinoamericana 2009;39(2):135-45.
2008: José Luis Cabriada; Valle García Sánchez; Fernando Gomollón; Joaquín Hinojosa; Antonio López San Román; Juan Luis Mendoza; Miguel Mínguez; Elena Ricart; Cristina Saro
[Recommendations for patients with Crohn's disease starting treatment with adalimumab: a rapid guide].
Gastroenterología y hepatología 2008;31(10):693-7.
2008: Fernando Gomollón
[Inflammatory bowel disease].
Gastroenterología y hepatología 2008;31 Suppl 4():42-6.
2008: Fernando Gomollón; Joaquín Hinojosa
[Steroids: friends or foes?].
Gastroenterología y hepatología 2008;31 Suppl 3():1-2.
2008: Javier P Gisbert; Fernando Gomollón
Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review.
The American journal of gastroenterology 2008;103(7):1783-800.
2008: Fernando Gomollón; Santiago García López
[Treatment with anti-TNFalpha agents in Crohn's disease: what drug we have to use and when?].
Acta gastroenterologica Latinoamericana 2008;38(2):133-45.
2008: Javier P Gisbert; Fernando Gomollón
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.
The American journal of gastroenterology 2008;103(5):1299-307.
2007: Javier P Gisbert; Fernando Gomollón
[Common errors in the management of outpatients with inflammatory bowel disease].
Gastroenterología y hepatología 2007;30(8):469-86.
2007: Marcos Díez; Elena Sánchez; Santiago García López; María Teresa Arroyo; Fernando Gomollón
[Infliximab therapy in ulcerative colitis: initial experience in two referral centers].
Gastroenterología y hepatología 2007;30(8):449-53.
2007: Javier P Gisbert; Fernando Gomollón
[Common errors in the management of the seriously ill patient with inflammatory bowel disease].
Gastroenterología y hepatología 2007;30(5):294-314.
2007: Javier P Gisbert; Fernando Gomollón; Carlos Cara; Marta Luna; Yago González Lama; José María Pajares; José Maté; Luis G Guijarro
Thiopurine methyltransferase activity in Spain: a study of 14,545 patients.
Digestive diseases and sciences 2007;52(5):1262-9.
2007: Angel Lanas; Luis A García-Rodríguez; María Teresa Arroyo; Luis Bujanda; Fernando Gomollón; Montserrat Forné; Sofía Aleman; David Nicolas; Faust Feu; Antonio González-Pérez; Ana Borda; Manuel Castro; Maria Jose Poveda; Juan Arenas
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
The American journal of gastroenterology 2007;102(3):507-15.
2007: Joaquín Hinojosa; Fernando Gomollón; S García; G Bastida; J L Cabriada; C Saro; D Ceballos; M Peñate; Miquel A Gassull
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial.
Alimentary pharmacology & therapeutics 2007;25(4):409-18.
2007: Julián Panés; Fernando Gomollón; carlos taxonera; Joaquín Hinojosa; Juan Clofent; Pilar Nos
Crohn's disease: a review of current treatment with a focus on biologics.
Drugs 2007;67(17):2511-37.
2006: Angel Lanas; L A García-Rodríguez; María Teresa Arroyo; Fernando Gomollón; Faust Feu; A González-Pérez; E Zapata; G Bástida; Luis Rodrigo; Santos Santolaria; M Güell; Carlos Martin de Argila; Enrique Quintero; Fernando Borda; Josep M Piqué
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
Gut 2006;55(12):1731-8.
2006: Eugeni Domènech; Fernando Gomollón; A Obrador; Julián Panés; Miquel A Gassull
Is oral ciclosporin necessary to switch from i.v. to thiopurines?
Alimentary pharmacology & therapeutics 2006;23(4):555-6; author reply 556-7.
2006: J L Cabriada; E Doménech; Fernando Gomollón; Pedro González Carro; V González-Lara; Joaquín Hinojosa; C E Jiménez-López; Pilar Nos; A Obrador; J Panès; C Saro; V Varea; R Lafuente; Magda Guilera
[Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease].
Gastroenterología y hepatología 2006;29(2):85-92.
2005: Javier P Gisbert; Xavier Calvet; Fernando Gomollón; Joan Monés
[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].
Medicina clínica 2005;125(8):301-16.
2005: Javier P Gisbert; Fernando Gomollón; Carlos Cara; Marta Luna; Yago González Lama; José María Pajares; José Maté; Luis G Guijarro
[Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].
Medicina clínica 2005;125(8):281-5.
2005: Eugeni Domènech; M Esteve; Fernando Gomollón; Joaquín Hinojosa; Julián Panés; A Obrador; Miquel A Gassull
[GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease].
Gastroenterología y hepatología 2005;28(3):126-34.
2005: Beatriz Sicilia; R Vicente; María Teresa Arroyo; F Arribas; Fernando Gomollón
[Surgery at follow-up in an incidence cohort of patients with Crohn's disease in Aragon (Spain): etiology, type of surgery and associated epidemiological factors].
Gastroenterología y hepatología 2005;28(3):105-9.
2005: Beatriz Sicilia; R Vicente; María Teresa Arroyo; F Arribas; Fernando Gomollón
[Ulcerative pancolitis predicts the need for colectomy: study of an incident cohort of patients with ulcerative colitis in Aragón (Spain)].
Gastroenterología y hepatología 2005;28(2):55-9.
2005: Fernando Gomollón; Xavier Calvet
Optimising acid inhibition treatment.
Drugs 2005;65 Suppl 1():25-33.
2005: Xavier Calvet; Fernando Gomollón
What is potent acid inhibition, and how can it be achieved?
Drugs 2005;65 Suppl 1():13-23.
2004: Eugeni Domènech; Joaquín Hinojosa; Maria Esteve-Comas; Fernando Gomollón; J M Herrera; G Bastida; A Obrador; R Ruiz; C Saro; Miquel A Gassull
Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Alimentary pharmacology & therapeutics 2004;20(11-12):1347-52.
2004: Fernando Gomollón; Santos Santolaria; Beatriz Sicilia; Miguel Ferrero; María José Revillo; Julio Ducóns; Margarita Villar; María Concepción Celaya; Miguel Montoro
[Helicobacter pylori resistance to metronidazole and clarythromicin: descriptive analysis 1997-2000].
Medicina clínica 2004;123(13):481-5.
2003: Fernando Gomollón; Julio Ducons; Santos Santolaria; I Lera Omiste; R Guirao; Miguel Ferrero; Miguel Montoro
Breath test is very reliable for diagnosis of Helicobacter pylori infection in real clinical practice.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(9):612-8.
2003: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
[The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].
Gastroenterología y hepatología 2003;26(5):312-24.
2003: Javier P Gisbert; Fernando Gomollón; J E Domínguez-Muñoz; Fernando Borda; I Jiménez; M A Vázquez; S Gallego; J Iglesias; G Pastor; J M Pajares
[Comparison between two 13C-urea breath tests for the diagnosis of Helicobacter pylori infection: isotope ratio mass spectrometer versus infrared spectrometer].
Gastroenterología y hepatología 2003;26(3):141-6.
2003: J Valdepérez; R Vicente; M P Novella; L Valle; Beatriz Sicilia; C Yus; Fernando Gomollón
[Is the breath test reliable in primary care diagnosis of Helicobacter pylori infection?].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2003;31(2):93-7.
2003: Javier P Gisbert; Julio Ducons; Fernando Gomollón; J E Domínguez-Muñoz; Fernando Borda; G Miño; I Jiménez; M A Vázquez; Santos Santolaria; S Gallego; J Iglesias; G Pastor; A Hervás; J M Pajares
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2003;95(2):121-6, 115-20.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; J M Figueroa; R Alós; José María Pajares
[Treatment of stenosis due to Crohn's disease].
Gastroenterología y hepatología 2002;25(9):560-9.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
[Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity].
Revista clínica española 2002;202(10):555-62.
2002: Fernando Gomollón
Celiac sprue.
The New England journal of medicine 2002;347(6):446-8; author reply 446-8.
2002: R Vicente; Beatriz Sicilia; S Gallego; María José Revillo; Julio Ducóns; Fernando Gomollón
[Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study].
Gastroenterología y hepatología 2002;25(7):438-42.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gastroenterología y hepatología 2002;25(6):401-15.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.
Digestive diseases and sciences 2002;47(3):471-88.
2002: Eugeni Domènech; Maria Esteve-Comas; Fernando Gomollón; Joaquín Hinojosa; A Obrador; Julián Panés; Miquel A Gassull
[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
Gastroenterología y hepatología 2002;25(3):162-9.
2001: Beatriz Sicilia; C López Miguel; F Arribas; J López Zaborras; E Sierra; Fernando Gomollón
Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(9):762-7.
2001: Fernando Gomollón; Beatriz Sicilia
Helicobacter pylori: strategies for treatment.
Expert opinion on investigational drugs 2001;10(7):1231-41.
2001: L M Valle; J Valdepérez; M Tirado; D Verduras; C Yus; Fernando Gomollón
[Failure of rapid serology for Helicobacter pylori as diagnostic method in primary care consultation].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2001;28(2):126-8.
2001: Javier P Gisbert; Fernando Gomollón; José Maté; J María Pajares
[Pharmacological treatment of fistulae in Crohn's disease].
Medicina clínica 2001;116(17):664-71.
2001: Pilar Nos; Joaquín Hinojosa; Fernando Gomollón; J Ponce
[Budesonide in inflammatory bowel disease: a meta-analysis].
Medicina clínica 2001;116(2):47-53.
2000: Beatriz Sicilia; E Sierra; A Lago; M Villar; S García; Fernando Gomollón
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy].
Medicina clínica 2000;115(17):641-3.
2000: Miguel Ferrero; Julio Ducóns; Beatriz Sicilia; Santos Santolaria; E Sierra; Fernando Gomollón
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.
International journal of antimicrobial agents 2000;16(3):245-8.
2000: Fernando Gomollón; Beatriz Sicilia; Julio Ducóns; E Sierra; María José Revillo; Miguel Ferrero
Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients.
Alimentary pharmacology & therapeutics 2000;14(10):1335-8.
2000: Fernando Gomollón; J Valdepérez; R Garuz; J Fuentes; F Barrera; J Malo; M Tirado; MA Simón
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Medicina clínica 2000;115(1):1-6.
2000: Fernando Gomollón
[Does Helicobacter pylori infection cause dyspepsia in the absence of ulcer?].
Gastroenterología y hepatología 2000;23 Suppl 2():21-4.
2000: Fernando Gomollón; Santos Santolaria; Julio Ducóns; R Guirao; J Vera; Miguel Montoro
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain].
Gastroenterología y hepatología 2000;23(2):62-5.
2000: S García; J Fuentes; Julio Ducóns; F Barrera; C Yus; Fernando Gomollón
Is 1-week treatment for peptic ulcer healing sufficient and safe?
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2000;92(1):5-12.
1999: Fernando Gomollón; Joaquín Hinojosa; Pilar Nos
[Budesonide and inflammatory bowel disease].
Gastroenterología y hepatología 1999;22(10):525-32.
1999: Fernando Gomollón; Julio Ducóns; Miguel Ferrero; J García Cabezudo; R Guirao; MA Simón; Miguel Montoro
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.
Helicobacter 1999;4(4):222-5.
1999: Beatriz Sicilia; E Sierra; María José Revillo; M Navarro; Fernando Gomollón
[Multidrug-resistant Salmonella a significant clinical problem?].
Gastroenterología y hepatología 1999;22(7):342-4.
1999: Julio Ducóns; Santos Santolaria; R Guirao; Miguel Ferrero; Miguel Montoro; Fernando Gomollón
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer.
Alimentary pharmacology & therapeutics 1999;13(6):775-80.
1999: Fernando Fernández-Bañares; Joaquín Hinojosa; JL Sánchez-Lombraña; E Navarro; J F Martínez-Salmerón; A García-Pugés; Ferran González-Huix; Juan Riera; V González-Lara; F Domínguez-Abascal; J J Giné; J Moles; Fernando Gomollón; Miquel A Gassull
Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).
The American journal of gastroenterology 1999;94(2):427-33.
1998: M L Martín Mir; J Val; J Fuentes; S García; C Yus; MA Simón; Fernando Gomollón
[Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].
Gastroenterología y hepatología 1998;21(9):432-6.
1998: S García López; Fernando Gomollón
[Pseudomembranous colitis].
Gastroenterología y hepatología 1998;21(6):302-13.
1998: Fernando Gomollón; Julio Ducóns; L Gimeno; J Fuentes; S García; J Vera; Miguel Montoro
The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain.
Helicobacter 1998;3(2):110-4.
1996: Fernando Gomollón; L Gimeno; J Valdepérez; C Yus; J Marzo; M C Pérez-Caballero
Eradication of helicobacter pylori among patients from a primary care practice.
The Journal of family practice 1996;43(6):551-5.
1996: L Gimeno; J Valdepérez; R Macipe; C Arruga; T Cabrera; Fernando Gomollón
[The value of symptoms in the diagnosis of peptic ulcer: an approximation to the primary care medium].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(11):753-6.
1995: Fernando Gomollón; Eduardo Bajador
Helicobacter pylori eradication and reinfection.
Lancet 1995;345(8965):1647.
1994: R Uribarrena; Eduardo Bajador; M A Simón; JJ Sebastián; Fernando Gomollón
[Omeprazole and cimetidine in the treatment of upper digestive hemorrhage].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1994;86(6):878-83.
1994: R Uribarrena; M A Simón; JJ Sebastián; Fernando Gomollón; Eduardo Bajador; M T Botella; T Cabrera
[The endoscopic management of postoperative biliary fistulae].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1994;86(4):739-42.
1992: Miguel Montoro; Fernando Gomollón; F Sopeña; E Prats; J Banzo; J P Gomollón; J López Zaborras; Angel Lanas; R Sáinz
[Gastric emptying of solids, acid secretion and tobacco in duodenal ulcer].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1992;82(2):83-6.
1991: Fernando Gomollón; E Prats; J A Ducons; R García; S Ferrer; J Banzo; R Sainz
[Gammagraphy with sucralfate labelled with technetium in esophagitis].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1991;80(1):1-4.
1991: F Sopeña; J M Nerin; E Prats; J Banzo; J A Ducons; J López Zaborras; Fernando Gomollón
[Gammagraphy with labeled leukocytes as an activity and extension index of Crohn disease].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1991;79(6):387-92.
1991: J Cebolla; J López Zaborras; F Sopeña; J M Nerín; Fernando Gomollón; R Sainz
[The epidemiological aspects of Crohn's disease in Zaragoza].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1991;79(3):186-9.
1987: Fernando Gomollón; E Prats; D García Pomar; Miguel Montoro; J Banzo; J López Zaborras; R Sáinz
[A new method for the diagnosis of peptic ulcer: gastric gammagraphy after the oral administration of sucralfate labeled with technetium. Preliminary results].
Revista española de las enfermedades del aparato digestivo 1987;72(4 Pt 2):411-3.
1986: Angel Lanas; J Alcalde; T Martínez; Fernando Gomollón; Miguel Montoro; J Morandeira; D Abos; R Sainz
[Effect of duodenal acidification on gastric secretion and levels of secretin: a comparative study in humans and dogs].
Revista española de las enfermedades del aparato digestivo 1986;70(1):13-7.
1985: Angel Lanas; Miguel Montoro; Fernando Gomollón; J Bueno; R Sainz
[Influence of tobacco on the levels of gastric secretion, pepsinogen I and the duodenal mechanism of inhibition of gastric secretion in duodenal ulcer patients].
Medicina clínica 1985;85(11):439-42.
1985: Angel Lanas; Miguel Montoro; C Poderos; Fernando Gomollón; R Sainz
[Physiopathological heterogeneity of peptic ulcer: approach to the identification of groups of duodenal ulcer patients].
Revista española de las enfermedades del aparato digestivo 1985;68(2):103-9.
1985: Angel Lanas; Miguel Montoro; Fernando Gomollón; J López; D Abos; R Sainz
[Influence of gastrin in the pathogenesis of duodenal ulcer].
Revista española de las enfermedades del aparato digestivo 1985;68(1):43-9.
1985: R Sainz; A Lanas Arbeloa; Javier Ortego; P Parra; Eduardo Bajador; Fernando Gomollón; Miguel Montoro
[Gastric hypersecretion and duodenal ulcer: suspected existence of a non-gastrin secretagogue through bioassay].
Revista española de las enfermedades del aparato digestivo 1985;67(5):391-5.
1982: R Sáinz; Angel Lanas; Fernando Gomollón; M Moros
Megacolon in Duchenne's disease.
Gastroenterology 1982;83(5):1155-6.